Craig P Hersh
Overview
Explore the profile of Craig P Hersh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
224
Citations
5889
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Nguyen H, Jeong Y, Kim Y, Kim Y, Athar H, Castaldi P, et al.
bioRxiv
. 2024 Jun;
PMID: 38826450
Significance Statement: Fibroblasts have a central role in the pathogenesis of fibrotic diseases. However, due to in part to multiple profibrotic stimuli, targeting a single activator of fibroblasts, like TGFβ,...
22.
Yang H, Ryu M, Carey V, Kinney G, Hokanson J, Dransfield M, et al.
J Am Heart Assoc
. 2024 May;
13(11):e033882.
PMID: 38818936
Background: Cardiovascular disease (CVD) is the most important comorbidity in patients with chronic obstructive pulmonary disease (COPD). COPD exacerbations not only contribute to COPD progression but may also elevate the...
23.
Sibilio P, Conte F, Huang Y, Castaldi P, Hersh C, DeMeo D, et al.
Heliyon
. 2024 May;
10(10):e31301.
PMID: 38807864
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous, chronic inflammatory process of the lungs and, like other complex diseases, is caused by both genetic and environmental factors. Detailed understanding of...
24.
Hu X, Kim J, Saferali A, Huang Y, Ma S, Bingham G, et al.
Am J Respir Crit Care Med
. 2024 Apr;
210(5):683-686.
PMID: 38626378
No abstract available.
25.
Schiavi E, Ryu M, Martini L, Balasubramanian A, McCormack M, Fortis S, et al.
Am J Respir Crit Care Med
. 2024 Apr;
210(11):1317-1328.
PMID: 38607551
For spirometry interpretation, the European Respiratory Society (ERS) and American Thoracic Society (ATS) recommend using -scores, and the ATS has recommended using Global Lung Initiative (GLI) "Global" race-neutral reference equations....
26.
Ryu M, Yun J, Kim K, Gentili M, Ghosh A, Sciurba F, et al.
medRxiv
. 2024 Apr;
PMID: 38585732
Rationale: Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are debilitating diseases associated with divergent histopathological changes in the lungs. At present, due to cost and technical limitations,...
27.
Saferali A, Kim W, Xu Z, Chase R, Cho M, Laederach A, et al.
Hum Mol Genet
. 2024 Apr;
33(13):1164-1175.
PMID: 38569558
While many disease-associated single nucleotide polymorphisms (SNPs) are expression quantitative trait loci (eQTLs), a large proportion of genome-wide association study (GWAS) variants are of unknown function. Alternative polyadenylation (APA) plays...
28.
Konigsberg I, Vu T, Liu W, Litkowski E, Pratte K, Vargas L, et al.
medRxiv
. 2024 Mar;
PMID: 38464285
Background: Studies have identified individual blood biomarkers associated with chronic obstructive pulmonary disease (COPD) and related phenotypes. However, complex diseases such as COPD typically involve changes in multiple molecules with...
29.
Lovelace T, Ryu M, Jia M, Castaldi P, Sciurba F, Hersh C, et al.
medRxiv
. 2024 Feb;
PMID: 38352364
Background-research Question: Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality. Predicting mortality risk in COPD patients can be important for disease management strategies. Although scores for all-cause...
30.
Maiorino E, De Marzio M, Xu Z, Yun J, Chase R, Hersh C, et al.
medRxiv
. 2024 Jan;
PMID: 38260473
Chronic Obstructive Pulmonary Disease (COPD) is a complex, heterogeneous disease. Traditional subtyping methods generally focus on either the clinical manifestations or the molecular endotypes of the disease, resulting in classifications...